Search
Menu
PI Physik Instrumente - Revolution In Photonics Align ROSLB 3/24

MDS Inc.

Facebook X LinkedIn Email
MDS Inc. of Toronto will acquire Molecular Devices Corp. of Sunnyvale, Calif., a manufacturer of cellular analysis and biochemical testing products for drug discovery and other life sciences applications. The deal is worth $615 million in cash, including $585 million for the purchase of outstanding shares and $30 million for outstanding stock options. The Canadian company intends to combine Molecular Devices and MDS Sciex to create a business unit with more than 1100 employees. Molecular Devices’ cellular analysis and biochemical screening products will retain their brand names, and MDS Sciex...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: March 2007
    Biophotonicscellular analysiscellular analysis and biochemical testing productsMDS Inc.News & Featuresspectroscopy

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.